Willis C. Lee - Feb 22, 2022 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Vice Chairman & COO, Director
Signature
Willis C. Lee
Stock symbol
EMMA
Transactions as of
Feb 22, 2022
Transactions value $
$31,463
Form type
4
Date filed
2/28/2022, 04:34 PM
Previous filing
Jan 5, 2022
Next filing
Apr 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $710 +500 +0.2% $1.42* 257K Feb 22, 2022 Direct
transaction EMMA Common stock, $0.001 par value Purchase $8.5K +5.9K +2.3% $1.44* 263K Feb 24, 2022 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $10.9K +7.2K +2.74% $1.51* 270K Feb 28, 2022 Direct F2
transaction EMMA Common stock, $0.001 par value Purchase $9.9K +6.6K +2.89% $1.50* 235K Feb 28, 2022 By Fidelity Traditional IRA FBO Willis C. Lee F3
transaction EMMA Common stock, $0.001 par value Purchase $1.49K +900 +90% $1.65* 1.9K Feb 28, 2022 By Fidelity Roth IRA FBO Willis C. Lee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.44, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.41 to $1.54, inclusive.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.60, inclusive.